Shareholders in AtriCure (NASDAQ:ATRC) Have Lost 58%, as Stock Drops 3.3% This Past Week

Simply Wall StDec 24 08:17 ET

AtriCure to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

BusinesswireDec 23 08:00 ET

Pain Management Devices Global Analysis Report 2024-2034 Featuring Abbott Laboratories, Boston Scientific, Medtronic, Nevro, Baxter, OMRON, Stryker, Teleflex, ICU Medical, AtriCure, and Zynex

Yahoo FinanceDec 18 06:48 ET

AtriCure Coverage Assumed by JP Morgan at Overweight

Dow JonesDec 17 07:33 ET

J.P. Morgan Maintains AtriCure(ATRC.US) With Buy Rating, Maintains Target Price $40

Moomoo NewsDec 17 06:31 ET · Ratings

Analysts Offer Insights on Healthcare Companies: Atricure (ATRC) and Mettler-Toledo (MTD)

TipRanksDec 17 05:50 ET · Ratings